Free Trial

Kiora Pharmaceuticals (KPRX) SEC Filings & 10K Form

Kiora Pharmaceuticals logo
$3.02 -0.07 (-2.11%)
As of 01:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Kiora Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/04/2025
1:34 PM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
5:59 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2025
6:02 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
9:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form DEF 14A
04/02/2025
7:10 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:11 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:14 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:15 PM
Hollander David (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Parsons Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:28 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Strem Brian M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:28 PM
Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:29 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
5:55 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2025
5:57 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2025
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
10:39 AM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/10/2025
7:38 AM
HIRSCHMAN ORIN (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/15/2025
4:22 PM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:17 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/14/2024
3:53 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/14/2024
3:32 PM
Alyeska Investment Group, L.P. (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SC 13G
11/13/2024
4:34 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
11/08/2024
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
6:01 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:32 AM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:02 AM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
12:00 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
2:45 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:17 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
6:01 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:01 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:02 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
Hollander David (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Parsons Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

07/03/2024
2:16 PM
Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Strem Brian M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:47 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
2:40 PM
Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:KPRX) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners